Evidence map›Paper›PMID 27107013›Full record

ArticleMolecular systems biology2016

Predictive features of ligand-specific signaling through the estrogen receptor.

Jerome C Nwachukwu, Sathish Srinivasan, Yangfan Zheng, Song Wang, Jian Min, Chune Dong, Zongquan Liao, Jason Nowak, Nicholas J Wright, René Houtman and 6 more

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Dual-mechanism estrogen receptor inhibitors.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Jerome C NwachukwuDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USA.ORCID http://orcid.org/0000-0003-4313-9187
Sathish SrinivasanDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USA.
Yangfan ZhengState Key Laboratory of Virology, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, China.
Song WangState Key Laboratory of Virology, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, China.
Jian MinDepartment of Chemistry, University of Illinois, Urbana, IL, USA.
Chune DongState Key Laboratory of Virology, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, China.
Zongquan LiaoState Key Laboratory of Virology, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, China.
Jason NowakDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USA.
Nicholas J WrightDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USA.
René HoutmanPamGene International, Den Bosch, The Netherlands.
Kathryn E CarlsonDepartment of Chemistry, University of Illinois, Urbana, IL, USA.
Jatinder S JosanDepartment of Chemistry, Virginia Tech, Blacksburg, VA, USA.
Olivier ElementoDepartment of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY, USA.
John A KatzenellenbogenDepartment of Chemistry, University of Illinois, Urbana, IL, USA knettles@scripps.edu jkatzene@illinois.edu zhouhb@whu.edu.cn.
Hai-Bing ZhouState Key Laboratory of Virology, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan, China knettles@scripps.edu jkatzene@illinois.edu zhouhb@whu.edu.cn.
Kendall W NettlesDepartment of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USA knettles@scripps.edu jkatzene@illinois.edu zhouhb@whu.edu.cn.ORCID http://orcid.org/0000-0003-2917-7574
Scripps Research Institute · USWuhan University · CNUniversity of Illinois Urbana-Champaign · USCornell University · USPamGene (Netherlands) · NLVirginia Tech · US

Funding

MOLECULAR PROBES FOR STEROID RECEPTORSR37DK015556 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1987 to 2012
$4.4M
Regulation of NFkappaB activity by the Estrogen ReceptorR01DK077085 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI NETTLES, KENDALL W · 2008 to 2012
$2.1M
Novel Ligands and Mechanisms to Achieve Selective Nuclear Receptor ActivityR01DK015556 · NIDDK · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1986 to 2016
$1.6M
Molecular Analysis of Steroid Hormone Receptors with X-ray CrystallographyR33CA132022 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI NETTLES, KENDALL W · 2008 to 2010
$1.1M
NCI NIH HHS 5R33CA132022NCI NIH HHS R33 CA132022NIDDK NIH HHS 5R01DK077085NIDDK NIH HHS 5R37DK015556NIDDK NIH HHS R01 DK015556NIDDK NIH HHS R01 DK077085NIDDK NIH HHS R37 DK015556
6 · The paper itself

Abstract

Some estrogen receptor-α (ERα)-targeted breast cancer therapies such as tamoxifen have tissue-selective or cell-specific activities, while others have similar activities in different cell types. To identify biophysical determinants of cell-specific signaling and breast cancer cell proliferation, we synthesized 241 ERα ligands based on 19 chemical scaffolds, and compared ligand response using quantitative bioassays for canonical ERα activities and X-ray crystallography. Ligands that regulate the dynamics and stability of the coactivator-binding site in the C-terminal ligand-binding domain, called activation function-2 (AF-2), showed similar activity profiles in different cell types. Such ligands induced breast cancer cell proliferation in a manner that was predicted by the canonical recruitment of the coactivators NCOA1/2/3 and induction of the GREB1 proliferative gene. For some ligand series, a single inter-atomic distance in the ligand-binding domain predicted their proliferative effects. In contrast, the N-terminal coactivator-binding site, activation function-1 (AF-1), determined cell-specific signaling induced by ligands that used alternate mechanisms to control cell proliferation. Thus, incorporating systems structural analyses with quantitative chemical biology reveals how ligands can achieve distinct allosteric signaling outcomes through ERα.

Indexed as

Binding SitesCell ProliferationEstrogen Receptor alphaFemaleGene Expression Regulation, NeoplasticHumansLigandsMCF-7 CellsModels, MolecularMolecular StructurePeptide LibraryProtein BindingSignal TransductionEstrogen Receptor alphaLigandsPeptide LibraryBreast cancerChemical biologyCrystal structureNuclear receptorSignal transduction

Identifiers

PMID27107013
PMCPMC4848761
OpenAlexW2338139510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.